Aclarion, Inc. (ACON) Stock

Aclarion, Inc. is a pioneering healthcare technology company based in San Mateo, California, specializing in the development of advanced software applications for magnetic resonance spectroscopy (MRS). The company's flagship product, the NOCISCAN-LS Post-Processor suite, includes NOCICALC-LS, which processes disc MRS data to accurately calculate levels of degenerative pain biomarkers. Additionally, Aclarion offers NOCIGRAM-LS, a clinical decision support software designed to aid healthcare professionals in interpreting MRS results and making informed treatment decisions.

Formerly known as Nocimed, Inc., Aclarion rebranded in December 2021 to reflect its expanded focus and growth within the healthcare technology sector. Since its establishment in 2008, the company has been committed to driving innovation in pain management and diagnostics through cutting-edge MRS technology. Aclarion's solutions empower clinicians with actionable insights to improve patient care and outcomes in the field of degenerative disc disease and beyond.

With a foundation rooted in technological innovation and a dedication to advancing medical diagnostics, Aclarion continues to lead the way in developing transformative solutions that enhance the precision and effectiveness of healthcare delivery. By leveraging its expertise in MRS and clinical decision support, Aclarion is poiised to make a significant impact in optimizing treatment strategies and improving the quality of life for patients world wide.